You have 9 free searches left this month | for more free features.

mammalian target of rapamycin

Showing 1 - 25 of 8,953

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Dietary Protein Trial in Saint Louis (Dietary protein shake)

Active, not recruiting
  • Dietary Protein
  • Dietary protein shake
  • Saint Louis, Missouri
    Washington University
Jan 29, 2023

Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer Trial in Miami (AI+CDK4/6i, SERD+CDK4/6i, mTOR inhibitor +

Not yet recruiting
  • Breast Cancer
  • +3 more
  • Miami, Florida
    University of Miami
Apr 12, 2023

Muscle Atrophy, Age-Related Sarcopenia Trial in Derby (Rapamune (sirolimus) 1Mg Tablet, Unilateral resistance exercise training)

Recruiting
  • Muscle Atrophy
  • Age-Related Sarcopenia
  • Rapamune (sirolimus) 1Mg Tablet
  • Unilateral resistance exercise training
  • Derby, United Kingdom
    University of Nottingham School of Medicine
Jun 7, 2022

Coronary Artery Disease, Coronary Stenosis Trial (Rapamycin target eluting stent)

Not yet recruiting
  • Coronary Artery Disease
  • Coronary Stenosis
  • Rapamycin target eluting stent
  • (no location specified)
Oct 13, 2021

Insulin Sensitivity Trial in Copenhagen (other, procedure, drug)

Recruiting
  • Insulin Sensitivity
  • Exercise
  • +3 more
  • Copenhagen, Denmark
    University of Copenhagen
Jun 20, 2022

Aging Trial (Sirolimus)

Not yet recruiting
  • Aging
  • (no location specified)
Nov 3, 2022

Coronary Artery Disease Trial in Worldwide (Microport Firehawk stent, 2nd generation DES (XIENCE family, Promus family,

Recruiting
  • Coronary Artery Disease
  • Microport Firehawk stent
  • 2nd generation DES (XIENCE family, Promus family, Resolute/Onyx family/Endeavor, and Orsiro stent)
  • Birmingham, Alabama
  • +56 more
Jul 25, 2022

Motor Neuron Disease Trial in Sydney, Melbourne (Monepantel)

Recruiting
  • Motor Neuron Disease
  • Sydney, New South Wales, Australia
  • +1 more
Jun 28, 2022

Vitiligo Trial in Charleston (Rapamycin, Placebo)

Recruiting
  • Vitiligo
  • Charleston, South Carolina
    Medical University of South Carolina
Aug 2, 2022

Activated PI3K-delta Syndrome, Immunodeficiency Primary Trial in Shanghai (Rapamycin)

Recruiting
  • Activated PI3K-delta Syndrome
  • Immunodeficiency Primary
  • Shanghai, Shanghai, China
  • +1 more
Mar 21, 2022

Acute Myelogenous Leukemia Trial in Rochester (Decitabine)

Completed
  • Acute Myelogenous Leukemia
  • Rochester, New York
    University of Rochester
Jul 1, 2022

Gallbladder Cancer Trial in Varanasi (Everolimus 10 mg, Standard of care)

Recruiting
  • Gallbladder Cancer
  • Everolimus 10 mg
  • Standard of care
  • Varanasi, UP, India
    Banaras Hindu University
Apr 18, 2023

Lymphangioleiomyomatosis, Tuberous Sclerosis Complex Trial in Boston ([11C]acetate)

Recruiting
  • Lymphangioleiomyomatosis
  • Tuberous Sclerosis Complex
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jul 20, 2022

Bronchiolitis Obliterans Syndrome Due to and After Lung Transplantation (Disorder), Chronic Lung Allograft Dysfunction Trial in

Recruiting
  • Bronchiolitis Obliterans Syndrome Due to and After Lung Transplantation (Disorder)
  • Chronic Lung Allograft Dysfunction
  • San Francisco, California
    University of California, San Francisco
Aug 28, 2023

Healthy Nutrition Trial (resistance training, ketogenic diet, western diet)

Not yet recruiting
  • Healthy Nutrition
  • resistance training
  • +2 more
  • (no location specified)
Jun 8, 2023

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

Active, not recruiting
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +9 more
  • Sewell, New Jersey
  • +4 more
Dec 13, 2022

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) Trial

Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +13 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Feb 2, 2023

Vascular Malformations Trial in Nijmegen (Sirolimus)

Active, not recruiting
  • Vascular Malformations
  • Nijmegen, Gelderland, Netherlands
    Radboudumc, HECOVAN workgroup
Jan 28, 2021

Peripheral Arterial Disease Trial (Rapamycin drug balloon angioplasty, Paclitaxel drug balloon angioplasty)

Not yet recruiting
  • Peripheral Arterial Disease
  • Rapamycin drug balloon angioplasty
  • Paclitaxel drug balloon angioplasty
  • (no location specified)
Aug 31, 2023

Vertebrobasilar Insufficiency Trial in Beijing (Drug-eluting stent)

Completed
  • Vertebrobasilar Insufficiency
  • Drug-eluting stent
  • Beijing, Beijing, China
    Beijing Tiantan Hospital
Jun 11, 2020

HNSCC Trial in Houston (Bimiralisib)

Terminated
  • HNSCC
  • Houston, Texas
    M.D. Anderson Cancer Center
Dec 22, 2021

Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Everolimus, Laboratory

Recruiting
  • Advanced Malignant Neoplasm
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 9, 2022

Classical Hodgkin Lymphoma Trial in Philadelphia (Itacitinib, Everolimus)

Active, not recruiting
  • Classical Hodgkin Lymphoma
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Nov 28, 2022

Solid Tumor, Adult, NSCLC, Advanced Cancer Trial (Adagrasib, nab-Sirolimus)

Not yet recruiting
  • Solid Tumor, Adult
  • +4 more
  • (no location specified)
Apr 24, 2023

Breast Tumor Malignant Female Trial in United States (Gedatolisib)

Available
  • Breast Neoplasm Malignant Female
  • Birmingham, Alabama
  • +4 more
Jul 25, 2022